Surgical site infections plague all surgeons throughout their career even with the utmost care taken to consider all factors that play a part in their development. With the emergence of multi-drug resistant bacteria, this has made a complicated problem even more difficult to manage. Methicillin resistant staphylococcus pseudintermedius (MRSP) evades many of our empirically selected antibiotics which leads to additional pain and suffering for the patient and cost for the owners while waiting for results from a culture and susceptibility. Unfortunately, the prevalence of MRSP has continued to increase over time so understanding factors that contribute to these infections is becoming even more important. The formation of biofilm on surgical implants is one area of research that has received attention more recently. Staphylococcus pseudintermedius is one bacteria capable of producing these complex aggregates which may contribute to the emergence of resistance when not appropriately treated.
